Condition
Organ Donor
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06734091Not ApplicableRecruiting
Rapid Processing and Immunohistochemistry Method for Optimising Diagnosis Time in Solid Organ Donors, Suspected Malignancy
NCT06611046Completed
MicroRNA Profile As a Biomarker of Liver Damage in Different Types of Liver Donors.
NCT03098706Not ApplicableCompletedPrimary
Therapeutic Hypothermia in "Expanded Criteria" Brain-dead Donors and Kidney-graft Function
NCT00310401Phase 2Completed
The Effect of Nebulized Albuterol on Donor Oxygenation
NCT01009125Not ApplicableCompletedPrimary
Healthcare Access and Utilization Among Living Kidney Donors
Showing all 5 trials